Astakhov Y - Search Results

1

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.

Uusitalo H, Egorov E, Kaarniranta K, Astakhov Y, Ropo A. Uusitalo H, et al. Among authors: astakhov y. Clin Ophthalmol. 2016 Mar 15;10:445-54. doi: 10.2147/OPTH.S91402. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27041987 Free PMC article.

2

Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.

Astakhov YS, Astakhov SY, Lisochkina AB. Astakhov YS, et al. Among authors: astakhov sy. Clin Ophthalmol. 2013;7:2289-97. doi: 10.2147/OPTH.S50446. Epub 2013 Dec 9. Clin Ophthalmol. 2013. PMID: 24353401 Free PMC article.

3

Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia, and Hungary.

Konstas AG, Hollo G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WC. Konstas AG, et al. Among authors: astakhov ys. Eur J Ophthalmol. 2006 Jan-Feb;16(1):60-6. doi: 10.1177/112067210601600111. Eur J Ophthalmol. 2006. PMID: 16496247

4

Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension.

Konstas AG, Irkec MT, Teus MA, Cvenkel B, Astakhov YS, Sharpe ED, Hollo G, Mylopoulos N, Bozkurt B, Pizzamiglio C, Potyomkin VV, Alemu AM, Nasser QJ, Stewart JA, Stewart WC. Konstas AG, et al. Among authors: astakhov ys. Eye (Lond). 2009 Jan;23(1):73-8. doi: 10.1038/sj.eye.6702995. Epub 2007 Oct 5. Eye (Lond). 2009. PMID: 17917683 Clinical Trial.

5

Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma.

Stewart WC, Kolker AE, Sharpe ED, Day DG, Konstas AG, Hollo G, Astakhov YS, Teus MA, Stewart JA. Stewart WC, et al. Among authors: astakhov ys. Eur J Ophthalmol. 2008 Sep-Oct;18(5):765-70. doi: 10.1177/112067210801800517. Eur J Ophthalmol. 2008. PMID: 18850556

6

Factors associated with long-term progression or stability in exfoliation glaucoma.

Konstas AG, Hollo G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WC. Konstas AG, et al. Arch Ophthalmol. 2004 Jan;122(1):29-33. doi: 10.1001/archopht.122.1.29. Arch Ophthalmol. 2004. PMID: 14718291

7

Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?

Holló G, Cvenkel B, Teus MA, Irkec MT, Astakhov YS, Chiselita D, Petkova N, Liehneová I, Kaluzny BJ, Kóthy P, Bozkurt B, Akopov EL, Stewart JA, Kristoffersen MS, Kristoffersen CJ, Stewart WC. Holló G, et al. Eur J Ophthalmol. 2010 Nov-Dec;20(6):1000-6. doi: 10.1177/112067211002000620. Eur J Ophthalmol. 2010. PMID: 20544681

8

Risk factors associated with progression in exfoliative glaucoma patients.

Holló G, Quaranta L, Cvenkel B, Astakhov YS, Teus MA, Kóthy P, Miglior S, Riva I, Akopov EL, Gros J, Stewart JA, Kristoffersen MS, Nelson LA, Stewart WC. Holló G, et al. Ophthalmic Res. 2012;47(4):208-13. doi: 10.1159/000332081. Epub 2011 Dec 16. Ophthalmic Res. 2012. PMID: 22178774 Free article.

9

Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.

Bressler SB, Barve A, Ganapathi PC, Beckmann K, Apte RS, Marcus DM, Baumane K, Agarwal S, Oleksy P, Reichstein DA, Patel SS, Ernest J, Dégi R, Gupta V, Kishino G, Kamei M, Loganathan S; INSIGHT Study Group. Bressler SB, et al. JAMA Ophthalmol. 2024 Oct 1;142(10):952-960. doi: 10.1001/jamaophthalmol.2024.3458. JAMA Ophthalmol. 2024. PMID: 39264599 Free PMC article. Clinical Trial.

10

TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.

Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters